Grant: China-Canada Joint Health Research Initiative
University of Toronto
$198,423.00
Role of protein acetylation in Mtb metabolism and virulence
FY 2012-13
Summary
The goal of this project is to identify acetylated proteins of Mycobacterium tuberculosis (Mtb) and elucidate the role of protein acetylation in Mtb metabolism and virulence. Mtb, the causative agent of tuberculosis (TB), infects one-third of the world's population and causes approximately 2 million deaths annually. The success of Mtb as a pathogen is partly due to its ability to adapt to and persist in diverse host microenvironments. During persistent infection in the host, Mtb is thought to exhibit reduced or altered metabolism and how Mtb coordinates its metabolism during different phase of infection remains incompletely understood. Protein lysine acetylation has been studied in the context of histone modification in eukaryotes. Recent studies show that acetylation of non-histone proteins occurs prevalently in both eukaryotes and prokaryotes. An emerging theme from these studies is that metabolic enzymes involved in central metabolic pathways and intermediary metabolisms are subjected to acetylation. Protein acetylation in Mtb has not been well studied. Given the intimate link of Mtb metabolism and infection, we hypothesize that protein lysine acetylation may play a critical role in Mtb metabolism and its adaptation to host microenvironments. The goal of our studies is to systematically identify these acetylated proteins and elucidate the role of protein acetylation in Mtb metabolism and virulence. Our studies may uncover novel targets for chemotherapeutic intervention. Screening of inhibitors of protein acetylation or deacetylation may be an attractive strategy for new drug development against TB.
Department
Program
China-Canada Joint Health Research Initiative
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
262553
Name
Liu Jun
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
National Natural Science Foundation of China (Haidian, Beijing)
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
China-Canada Joint Health Research Initiative - Grants Program
Projecttitle
Role of protein acetylation in Mtb metabolism and virulence
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$198,423
Cihrequipment2
$0
Programname2
China-Canada Joint Health Research Initiative
Keyworddelim
Metabolism; Mycobacterium Tuberculosis; Protein Acetylation; Virulence
Abstract
The goal of this project is to identify acetylated proteins of Mycobacterium tuberculosis (Mtb) and elucidate the role of protein acetylation in Mtb metabolism and virulence. Mtb, the causative agent of tuberculosis (TB), infects one-third of the world's population and causes approximately 2 million deaths annually. The success of Mtb as a pathogen is partly due to its ability to adapt to and persist in diverse host microenvironments. During persistent infection in the host, Mtb is thought to exhibit reduced or altered metabolism and how Mtb coordinates its metabolism during different phase of infection remains incompletely understood. Protein lysine acetylation has been studied in the context of histone modification in eukaryotes. Recent studies show that acetylation of non-histone proteins occurs prevalently in both eukaryotes and prokaryotes. An emerging theme from these studies is that metabolic enzymes involved in central metabolic pathways and intermediary metabolisms are subjected to acetylation. Protein acetylation in Mtb has not been well studied. Given the intimate link of Mtb metabolism and infection, we hypothesize that protein lysine acetylation may play a critical role in Mtb metabolism and its adaptation to host microenvironments. The goal of our studies is to systematically identify these acetylated proteins and elucidate the role of protein acetylation in Mtb metabolism and virulence. Our studies may uncover novel targets for chemotherapeutic intervention. Screening of inhibitors of protein acetylation or deacetylation may be an attractive strategy for new drug development against TB.
Competitiondate
201205
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Liu, Jun; Zhang, Xuelian
Approvedterm
3 ans 0 mois
Cihrcontribution2
Inst of Neurosc Mental Hlth &A~ $198,423~ $0~